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Human herpesvirus 6B (HHV-6B) is the causative agent of roseola infantum. HHV-6A and 6B can
reactivate in immunosuppressed individuals and are linked with severe inﬂammatory response, organ
rejection and central nervous system diseases. About 0.85% of the US and UK population carries an
integrated HHV-6 genome in all nucleated cells through germline transmission. We have previously
reported that the HHV-6A genome integrated in telomeres of patients suffering from neurological
dysfunction and also in telomeres of tissue culture cells. We now report that HHV-6B also integrates in
telomeres during latency. Detailed mapping of the integrated viral genomes demonstrates that a single
HHV-6 genome integrates and telomere repeats join the left end of the integrated viral genome. When
HEK-293 cells carrying integrated HHV-6A were exposed to the histone deacetylase inhibitor Trichostatin
A, circularization and/or formation of concatamers were detected and this assay could be used to
distinguish between lytic replication and latency.
& 2013 Elsevier Inc. All rights reserved.Introduction
Herpesviruses are ubiquitous and have adapted a balance of
lytic and latent infection within the infected host. Human herpes-
virus 6 (HHV-6) was isolated from B-lymphocytes of patients with
lymphoproliferative disorders while coinfected with HIV and HTLV
(Salahuddin et al., 1986). Further molecular studies as well as
sequencing of clinical isolates determined that humans carry two
different viral species: HHV-6A and HHV-6B (Ahlqvist et al., 2005;
Dominguez et al., 1999; Gompels et al., 1995; Yamanishi et al.,
1988).
Human herpesvirus 6B (HHV-6B) primary infection in young
children is the etiological agent of exanthema subitum (roseola
infantum), which is characterized by high fever, diarrhea, and a
mild skin rash along the trunk, neck, and face (Asano et al., 1994;
Yamanishi et al., 1988). Serologic studies have found that by thell rights reserved.
V-6, chromosome integrated
nuclear cells; STELA, single
College of Medicine, 12901
813 974 7357.
edveczky).age of two, greater than 90% of children have acquired a primary
HHV-6A/B infection (Okuno et al., 1989; Zerr et al., 2005). HHV-6A
has been associated with several adult diseases and various
neurological disorders including encephalitis, ataxia, seizures,
multiple sclerosis, Hashimoto's thyroiditis, and has been impli-
cated as a cofactor in AIDS progression (Ablashi et al., 2010;
Ahlqvist et al., 2005; Cameron et al., 2010; Caselli et al., 2012; De
Bolle et al., 2005; Donati et al., 2003; Jones et al., 1994; Lusso et al.,
2007, 1989; Yamashita and Morishima, 2005; Yao et al., 2010).
Nevertheless, the causal link between human disease and HHV-6A
infection remains to be fully elucidated.
The viral genome of HHV-6B is 162 kbp long, encompassing 119
unique open reading frames (ORF), while HHV-6A genome con-
tains 119 unique ORF and is 159 kbp long (Dominguez et al., 1999;
Gompels et al., 1995). The genome of HHV-6A and HHV-6B is
organized into two major regions (Fig. 1a). The unique (U) region
of the genome is 143 kbp and comprises seven major core gene
blocks that are conserved amongst Herpesviridae. The second
major genomic regions of HHV-6A and HHV-6B are the ∼8 kbp
of left and right direct repeats (DR) located at the termini of the
U region (Dominguez et al., 1999; Gompels et al., 1995). Within the
right end direct repeat (DRR) and the left end direct repeat (DRL)
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TTAGGG telomere repeat arrays.
Primary infection of HHV-6A/B leads to an increase in viral
copies present in peripheral blood and subsequent decrease
in viral copies during latency (Asano et al., 1994; De Bolle et al.,
2005; Okuno et al., 1989; Yamanishi et al., 1988; Zerr et al., 2005).
Following primary infection, the genome of most herpesviruses
establishes latency as multi-copy circular episomes within the
nucleus of the infected cell (reviewed by Pellett and Roizman,
2007). The expression of latent viral genes allows the stable
replication and persistence of the latent viral episomes. However,
no multi-copy episomes were detected in latently infected
HHV-6A and 6B cells (Arbuckle et al., 2010). Through the use of
ﬂuorescent in situ hybridization (FISH), Gardella gel, Southern
hybridization, and direct sequencing of viral integration sites from
patient tissues and establishment of in vitro integrated cell
lines our laboratory has demonstrated that HHV-6A speciﬁcally
integrates into telomeres of chromosomes (Arbuckle et al., 2010;
Arbuckle and Medveczky, 2011). These experiments suggest that
homologous recombination occurs between the perfect TTAGGG
telomere repeat arrays encoded in DRR of HHV-6A genome with
the subtelomere of the human chromosome.
In approximately 0.8% of the US and UK general population, high
copies of HHV-6 genomes can be detected in peripheral blood
measuring greater than 0.5 million copies per ml of blood and
referred to as chromosomally integrated HHV-6 or CIHHV-6
(Arbuckle et al., 2010; Hall et al., 2008, Leong et al., 2007; Ward
et al., 2006; Ward et al., 2005). Furthermore, Luppi et al. (1993)
identiﬁed a unique high molecular weight viral fragment present in
PBMCs of three patients with elevated copies of HHV-6. This high
molecular weight fragment resolved by pulse ﬁeld gel electrophor-
esis demonstrated one of the earliest observations of HHV-6
integration into the human genome. Subsequently, several other
labs have suggested integration of HHV-6 into human chromo-
somes through FISH and HHV-6 DNA sequences were detected in
hair follicles, lymph node, spleen, kidney, brain, liver, and cardiac
tissues by PCR (Daibata et al., 1998; Jarrett et al., 1988; Nacheva
et al., 2008; Strenger et al., 2010; Ward et al., 2006; Arbuckle et al.,
2010).
In this study we set out to further map the genome structure of
chromosome integrated HHV-6A and 6B. Here we show that
similarly to HHV-6A, the HHV-6B genome integrates into telo-
meres of human chromosomes near the subtelomere via the
perfect TTAGGG telomere repeat array encoded in DRR of the viral
genome. Single telomere length analyses (STELA) suggest that the
physical end of chromosome harboring the integrated virus
comprises telomeric repeats of variable length similar to those
found in normal chromosomes. Finally, latently infected HEK-293
cells containing integrated viral genome were exposed to the
histone deacetylase inhibitor Trichostatin A. Circularization and/
or formation of concatamers were detected by a novel PCR assay
indicating reactivation of HHV-6 from latency.Results
HHV-6B integrates in telomeres in vitro
Since we have previously demonstrated the genome of HHV-6A
integrates into telomeres of human chromosomes (Arbuckle et al.,
2010), we hypothesized that the genome of HHV-6B would as well
integrate into the telomeres of chromosomes during the course of
infection. Furthermore, the T-cell line Molt3 is routinely used to
propagate HHV-6B, yet we observed that cell lysis was often
incomplete and many cells survived after the peak of productive
infection possibly due to latent infection. DNA was isolated fromHHV-6B infected Molt3 cells and PCR ampliﬁed for the putative
viral genome-chromosome telomere junctions using subtelomere
based primers (2p, 11q, 12q, 17p, and 18q) and a primer annealing
to the right end of HHV-6B DRR (Fig. 1b).
The primer to DRR was utilized since our previously published
results determined that HHV-6A in vivo and in vitro integration
occurs through the linkage of perfect telomere array encoded in
DRR with the telomere sequence directly adjacent to the end of
the chromosome (Fig. 1b) (Arbuckle et al., 2010). Ampliﬁed
fragments from the subtelomeres of 2p, 11q, 12q, 17p, and 18q
were fractionated on an agarose gel and Southern hybridization
was performed with [γ32P]-ATP-radiolabeled TTAGGG probe that
hybridizes to both chromosome and HHV-6B telomere sequences
located at their termini. As illustrated in Fig. 1c, PCR ampliﬁcation
coupled with Southern hybridization identiﬁed the linkage of the
DRR of HHV-6B genome with the telomere of speciﬁc chromo-
somes during in vitro infection of Molt3 cells.
To conﬁrm the speciﬁc integration of HHV-6B into the telomere
of chromosomes 2p, 11q, and 18q, we ﬁrst cloned the PCR
ampliﬁed fragments through pCRs4-TOPOs cloning system.
Following transformation of competent cells, positive clones were
identiﬁed by colony hybridization with [γ32P]-ATP-radiolabeled
HHV-6B and telomere oligonucleotide probes. Sequencing of
clones conﬁrmed in vitro infection of Molt3 cells resulted in the
HHV-6B genome covalently linked with the telomere of chromo-
somes 2p, 11q, and 18q (Figs. 1d and S1). Therefore, the results
from these experiments illustrate that similar to HHV-6A
(Arbuckle et al., 2010), HHV-6B also speciﬁcally integrates into
telomeres of chromosomes during the course of infection through
the perfect telomere repeat array encoded in the DRR of the viral
genome.
Mapping the DRL from the integrated HHV-6 genome
Results in the previous section and publications by our group
identiﬁed the integration of HHV-6B and HHV-6A occurs through
recombination with the perfect telomere repeats encoded in the DRR
(Fig. 1) (Arbuckle et al., 2010; Arbuckle and Medveczky, 2011).
Therefore, we sought to further characterize the genomic structure
of the integrated HHV-6A and HHV-6B genomes through mapping of
the DRL region and determine whether the tandem array of telomere
repeats [(TTAGGG)n] was extended beyond the DRL (Figs. 1b and 2a).
During the process of integration into chromosome telomeres, it is
unknown whether recombination occurs with the DRL perfect or
imperfect telomere repeats (Fig. 1a and b). If recombination occurs
through the perfect telomere repeats, the DRL could potentially be
lost during the process of telomere integration. To map various
portions of the integrated viral genome in patients with CIHHV-6, we
developed two PCR based assays to determine whether the entire
DRL is present or absent (Fig. 2a).
In the ﬁrst experiment, ampliﬁcation of the DRL was completed
by using primers that annealed to the DRL and unique region of
the integrated genome (Fig. 2a, Primer 1¼P1 and Primer 2¼P2),
which effectively ampliﬁed across the perfect telomere repeat
(Fig. 2a, short dark square). Genomic DNA isolated from Family-1
members with CIHHV-6 (Arbuckle et al., 2010) was subjected to
this PCR based assay. The DRL was successfully ampliﬁed as shown
by Southern hybridization with telomere speciﬁc oligonucleotide
probe (Fig. 2b).
To conﬁrm the results in the previous experiment, we evalu-
ated the DRL in a second group of patients with inherited HHV-6
and utilized a second primer set (P3 and P4) in combination with
DraI restriction enzyme digestion (Fig. 2a). The PCR ampliﬁed DRL
fragment has two DraI restriction sites that lead to the expected
fragment sizes of 1027, 217, 186 bp according to the CIHHV-6A
genome (strain U1102) (Gompels et al., 1995). Similarly to the
Fig. 1. Ampliﬁcation of subtelomere-HHV-6B junction fragments from in vitro-infected Molt3 cells. (a) Genome structure of HHV-6B and HHV-6A in which unique (U) region
is surrounded by left and right direct repeats (DRL and DRR) containing perfect (dark bars) and imperfect (shaded bars) telomere repeats. (b) The putative model of the
integrated HHV-6-chromosome structure. Arrows indicate position of primers derived from the DRR of the HHV-6 genome and from a speciﬁc chromosome subtelomere. (c)
DNA from HHV-6B (strain Z29) infected and uninfected Molt3 cells were subjected to ampliﬁcation by PCR primers derived from HHV-6B DRR and subtelomere primers 2p,
11q, 12q, 17p and 18q (primer positions depicted in Fig. 1b). PCR products from virus-chromosome telomere junction were separated by electrophoresis and analyzed by
Southern blot hybridization utilizing a 32P-labeled telomere oligonucleotide probe. (d) DNA sequencing results of cloned fragments (n¼3) of chromosome 2p subtelomere
(upper) joined with TTAGGG telomere repeats (bold and underlined), and HHV-6B DRR sequence (lower) during viral integration into chromosome telomere. Additional
sequencing results are shown in Fig. S1.
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inherited CIHHV-6 genome of all patients as this fragment hybri-
dized with the oligonucleotide probe corresponding to the DraI–
DraI fragment (Fig. 2c). In summary, results demonstrate the
conservation of the CIHHV-6 DRL segment.
Telomere repeats are covalently linked to the DRL of integrated HHV-6
genome
The next series of experiments were designed to determine
whether a tandem array of telomere repeats [(TTAGGG)n] at the
end of the chromosome is linked to the DRL of the integratedHHV-6 genome. We adapted the methodology of Baird et al. single
telomere length analysis (STELA) assay (Baird et al., 2003; Britt-
Compton et al., 2006) to amplify and estimate the overall telomere
length from a speciﬁc chromosome end (Fig. 3a). Genomic DNA
was isolated from PBMCs of patients with inherited CIHHV. Next, a
oligonucleotide linker (Tellorette-2) containing a single TTAGGG
repeat was ligated to the end of the telomere by incubating 60 ng
and 150 ng of genomic DNA with T4 ligase for 13 h at 35 1C
(Fig. 3a). Linker-ligated DNA was ampliﬁed with a high ﬁdelity
Taq polymerase, linker annealing primer (P1), and a HHV-6 primer
annealing to the DRL (P2). The speciﬁc ampliﬁcation of the
chromosome telomere was identiﬁed through Southern
Fig. 2. Ampliﬁcation and restriction enzyme digestion of DRL fragments from DNA isolated from PBMC of members of a family with CIHHV-6. DNA from PBMC of members
of Family-1 (Arbuckle et al., 2010) carrying HHV-6A integrated in telomere of chromosome 18q, Patients 7–9 carrying HHV-6B integrated, and Jjhan cell line infected with
HHV-6A U1102 was subjected to PCR ampliﬁcation using primer pairs as depicted. (a) Diagram for the ampliﬁcation of DRL in which primer 1 (P1) and 3 (P3) bind to regions
inside DRL and primer 2 (P2) and 4 (P4) binds within the U of HHV-6. DraI restriction sites are indicated by arrows. (b) Ampliﬁcation of DRL with primers P1 and P2 from
members of Family-1 results in the predicted size of 1,198 bp (HHV-6A U1102) as shown in the ethidium bromide (Etbr) staining (left panel). Southern hybridization with
telomere oligonucleotide probe (right panel). Controls: HHV-6A (U1102) positive control while Family-1/Mother and Jjhan were negative controls. (c) Ampliﬁcation and
restriction digestion with DraI results in the predicted 1027, 217, 186 bp (HHV-6A U1102) as shown in the ethidium bromide (Etbr) staining (left panel). Southern
hybridization with HHV-6 DRL oligonucleotide probe hybridizes with DRL 1027 bp band (right panel). Controls: HHV-6A (U1102) infected Jjhan DNA positive control and
Jjhan negative control.
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tide probe (Fig. 3b–d). Subsequently, the nitrocellulose blot was
then stripped and re-hybridized with PCR ampliﬁed fragment
from the viral DRL. Co-hybridization of bands with telomere and
DRL probes conﬁrmed the covalent linkage of chromosome telo-
mere with the DRL of inherited HHV-6 genome (Fig. 3a). Moreover,
similar results were also obtained in STELA analysis of HEK-293
cell line harboring integrated HHV-6A (Fig. 3d). Heterogeneous
banding pattern was observed when DNA from uninfected HEK-
293 and Jjhan cells were subjected to STELA of chromosome Xp
(Fig. S2). The heterogeneity of PCR ampliﬁed telomere fragments
with the STELA assay has also been previously observed by Baird
et al. in control human cells (Baird et al., 2003; Britt-Compton
et al., 2006); this heterogeneity is likely due to the ampliﬁcation of
telomeres from a mixed populations of cells that contain variablelengths of telomeric sequence. The wide range of telomere length
heterogeneity has been described by several other methods
(reviewed by Lauzon et al., 2000).
Next using the STELA assay we determined the speciﬁc
telomere length of DNA isolated from PBMCs of patients with
inherited CIHHV-6A integrated into chromosome 17p. Calcula-
tion of the mean molecular weight of all bands co-hybridizing
with telomere and DRL (HHV-6A) radiolabeled probes from -
eight different PCR reactions was according to the protocol of
Baird et al. (2003) and Britt-Compton et al. (2006). The mean
telomere length of Sibling-2 and Sibling-1 was 5158 bp and
6309 bp, respectively (Fig. 3b and c). Therefore, the structure
of the in vivo and in vitro integrated HHV-6A/B genome is as
follows: chromosome-subtelomere-(TTAGGG)n-DRR-U-DRL-(TTAGGG)n
(Fig. 3a).
Fig. 3. STELA of DRL adjoining telomere in PBMCs of in vivo integrated HHV-6 and in vitro integrated HEK-293 cells. (a) Diagram illustrating the strategy of single telomere
length analysis (STELA) (Baird et al., 2003; Britt-Compton et al., 2006). To amplify the speciﬁc chromosome telomere extended beyond the DRL of the integrated HHV-6
genome a linker (Telorette-2) oligonucleotide is ligated to the end of the telomere. The Telorette-2 ligation reaction contained 60 or 150 ng genomic DNA (EcoRI digested +/−
for DNA solubilization). From this initial ligation, both ligation reactions are then serially diluted two-fold (indicated by the triangles in panels b, c and d) and subsequently
ampliﬁed with primers P1 and P2. Genomic DNA isolated from PBMCs from CIHHV-6A individuals mapped to chromosome 17p13.3 was subjected to STELA; (b) sibling-2,
and (c) sibling-1 of Family-1 (Arbuckle et al., 2010). (d) STELA was also performed on HEK-293 cells harboring telomere-integrated HHV-6A strain U1102 (Arbuckle et al.,
2010). In each ﬁgure, mean telomere length is calculated from co-hybridization of telomere (left panel) and HHV-6 probes (right panel).
J.H. Arbuckle et al. / Virology 442 (2013) 3–11 7Trichostatin A promotes formation of circular/catenated viral
genomes in latently infected cells
In our previous study we have demonstrated the histone
deacetylase inhibitor Trichostatin A (TSA) can induce reactivation
of the integrated CIHHV-6A viral genome from individuals’ PBMCs
as well as latently infected cell lines as evidenced by increase in
viral DNA copies upon exposure to the TSA (Arbuckle et al., 2010).
We hypothesized that reactivation of integrated CIHHV-6 genome
resulted in formation of circular replication intermediates and/or
tandem catenated forms of the genome as described for HHV-6
(Dominguez et al., 1999) and with other herpesviruses (Jacob et al.,
1979; Poffenberger and Roizman, 1985). To test this hypothesis,
HEK-293 cells latently infected and harboring integrated HHV-6A
(strain U1102) (Arbuckle et al., 2010) were cultured in the presence
of TSA at concentrations ranging from 10 ng/ml to 160 ng/ml for
3 days. Detection of viral episomes and/or concatemers was
performed by PCR ampliﬁcation of the DR by two primers that
annealed to either end of the unique region of HHV-6A genome(Fig. 4a). Thus, ampliﬁcation of DR would only occur during
circularization or catenation of the viral genome in a head-to-tail
conformation (Borenstein and Frenkel, 2009; Borenstein et al.,
2010; Jacob et al., 1979; Martin et al., 1991; Poffenberger and
Roizman, 1985; Severini et al., 2003). PCR products were subjected
to sequential Southern hybridization with oligonucleotide probes
to telomere, DR, and U regions of HHV-6A. The autoradiograms
revealed that all three probes hybridized with PCR products of
variable length from DNA isolated from cells that were treated
with TSA (Fig. 4b, hybridization with telomere probe is shown)
and not from control unstimulated or uninfected cells. Further-
more, similar variable fragments were also detected in control
HHV-6A infected Jjhan cells. The ampliﬁcation of variable size
bands is likely due to insertion of variable number of telomere
repeats in the DR during reactivation mediated by homologous
recombination with telomere sequences. The absence of catenated
genomes in latently infected cells also indicates that only a single
genome integrates in telomeres. We studied two additional HEK-
293 cell lines latently infected with HHV-6 and harboring telomere
Fig. 4. Treatment of HHV-6A latently integrated HEK-293 cells with the histone
deacetylase inhibitor TSA induces novel PCR products consistent with episome and/
or concatemer formation during induction of lytic viral DNA replication.
(a) Schematic illustration of rolling-circle replication of HHV-6 results in the
formation of concatemers of viral genomes. Arrows indicate the location of primers
utilized in the ampliﬁcation of DR. (b) Latently infected, single-cell cloned and
uninfected control HEK-293 cells were cultured with TSA at concentrations of
160 ng/ml, 80 ng/ml, 40 ng/ml, 20 ng/ml and 10 ng/ml and without drug treatment
(Neg) for 3 days. DR ampliﬁcation and Southern hybridization with DR oligonu-
cleotide probe demonstrate the induction of DNA fragments ampliﬁable with the
primers in DNA from cells treated with TSA. No ampliﬁcation was detected in
untreated 293/HHV-6A or 293 cells (Negative controls). Bands of variable size were
also detected in DNA from Jjhan cells cultures infected with HHV-6A.
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evidence for circularization/catenation was detected after TSA
induction presumably due to integration of defective viral gen-
omes (data not shown).Discussion
The integration of HHV6-B and HHV-6A into the telomeres of
human peripheral mononuclear cells in vivo and following in vitro
infection of Jjhan T-cells, Molt3 T-cells, and HEK-293 cells is
demonstrated (Fig. 1) (Arbuckle et al., 2010; Arbuckle and
Medveczky, 2011). It appears that in cell lines capable of support-
ing productive, lytic infection, some of the cells quickly become
latently infected through chromosomal integration, and remain
viable. Thus, HHV-6B and HHV-6A integration is not an unusual
dead-end phenomenon as described for other herpesviruses, but
an alternative mechanism of achieving latency.
These results suggest that HHV-6B and HHV-6A integrate into
the host genome via homologous recombination with human
telomeres. In particular, integration of HHV-6B and HHV-6A occurs
through recombination of the perfect telomere repeats encoded in
the DRR juxtaposed to the subtelomeric end of the chromosome
(Figs. 1, S1, and 2) (Arbuckle et al., 2010). Moreover, the tandem
array of telomere repeats [(TTAGGG)n] at the end of chromosomes
was shown to extend beyond the DRL of the HHV-6 genome
(Fig. 3). Therefore, the structure of the telomere integrated HHV-6
is as follows: chromosome-subtelomere-(TTAGGG)n-DRR-U-DRL-
(TTAGGG)n (Fig. 3a) (Arbuckle et al., 2010).Delecluse et al. (1993) previously demonstrated the latent
telomere-integrated Marek's Disease Virus (MDV) of chickens can
also reactivate. MDV integrants were detected as long concatamers
suggesting that MDV integration requires initiation of DNA
replication and catenation. In contrast, our data show that a
single HHV-6 genome integrates immediately following infection.
Taken together, these observations suggest the mechanism of
integration of the HHV-6/B and MDV are mediated by different
mechanisms.
Current diagnostic assays for the detection of reactivated are
based on quantitative PCR to determine viral copy number,
however quantitative PCR cannot distinguish between actively
replicating HHV-6 or latency. Demonstration of catenation/circu-
larization of replicating virus as described in this work can be used
in clinical studies to verify that the virus is indeed replicating
(Fig. 5).
Telomere position effects (TPE) is characterized by transcrip-
tional repression of telomere adjacent genes through the enrich-
ment of H3K9 methylation and decrease in activating H3K4
methylation emanating from the constitutive heterochromatin
state of the telomere (Ottaviani et al., 2008). The epigenetic
regulation by TPE is well characterized in Saccharomyces cerevisiae
(Gottschling et al., 1990; Ottaviani et al., 2008; Tham and Zakian,
2002; Wyrick et al., 1999). The use of reporter systems (GFP,
luciferase, URA3) has identiﬁed TPE in excess of 20 kbp down-
stream of the telomere sequence in S. cerevisiae. However less
established in human cells, Baur et al. (2001) observed a 10 fold
decrease in the expression of telomere adjacent luciferase reporter
when compared to reporter integrated near the centromere.
Moreover, the heterochromatin state of TPE was reversible after
treatment of human cells with TSA. This resulted in the suppres-
sion of HDACs and transcriptional activation of the luciferase
reporter, which parallels the TSA mediated reactivation of
HHV-6A from its latent integrated state (Arbuckle et al., 2010).
The impact of TPE on HHV-6 and cellular gene expression is
unknown. In particular, it is intriguing whether TPE plays a role in
transcriptional repression of lytic HHV-6 genes thus maintaining
viral latency during integration. Furthermore, it is unknown
whether integration of the ∼160 kb HHV-6 genome would alter
expression of nearby cellular genes due to interruption/alteration
of TPE.
Integration of the viral genome may also alter stability of
telomeres of the affected chromosome. We thus far have shown
that the viral DRR of the genome is integrated within
5–41 telomere repeats from the end of the chromosome (Figs. 1
and S1) (Arbuckle et al., 2010). The proximity of the ∼160 kbp
HHV-6 genome integrated between the end of the chromosome
and tandem array of telomere repeats suggests that the virus has a
minimal impact on the telomere/shelterin complex. However, if
the HHV-6 genome were to integrate near the end of the telomere,
one would expect progressive shortening of the telomere and the
viral genome. Subsequently, this loss may lead to chromosome
instability as the result of chromosome fusion, replicative senes-
cence, or the inability of the shelterin complex to bind the non-
telomere coding sequence of the virus to form the protective cap
at the end of telomere. These intriguing questions are currently
being addressed.
The studies presented here and earlier (Arbuckle et al., 2010;
Arbuckle and Medveczky, 2011) lead to some important questions
across ﬁelds of virology, telomere biology, DNA recombination/
repair, and inheritance. Future experiments are needed to deter-
mine the overall clinical impact of germ-line integrated CIHHV-6.
To conclude, we have provided further results supporting that
HHV-6A and HHV-6B are unique among human herpesviruses: they
have the potential to speciﬁcally integrate into telomeres of
chromosomes as described for CIHHV-6 individuals and also
Fig. 5. Proposed model for latent HHV-6 in vitro reactivation. During latency, HHV-6A and HHV-6B can integrate into the telomeres during in vivo and in vitro infection.
However, reactivation of integrated HHV-6 can be achieved through culturing of latently integrated cells with TSA, or alternatively, TPA plus hydrocortisone. (b) Reactivation
of the integrated HHV-6 results in genome replication through rolling-circle replication.
J.H. Arbuckle et al. / Virology 442 (2013) 3–11 9in vitro under experimental conditions. Moreover, the integrated
viral genome is capable of reactivation to produce infectious
virions (Arbuckle et al., 2010) and here we designed a PCR-based
assay to test clinical specimens for actively replicating HHV-6A
and HHV-6B.Materials and methods
Primary T-cells, cell lines, and viruses
Heparinized peripheral blood from patients with germ-line
inherited CIHHV-6 was obtained from the HHV-6 Foundation, after
the subjects gave informed consent (Arbuckle et al., 2010). Peripheral
blood mononuclear cells (PBMCs) were isolated using Lymphoprep™,
according to the manufacturer's protocol. PBMCs were incubated in
RPMI-1640 medium containing 10% FBS, 50 μg/ml gentamycin, and
5 μg/ml phytohemagglutinin (PHA, Sigma-Aldrich) for 72-h, followed
by culturing in 100 U/μl IL-2 medium. T-cell lines Jjhan (HHV-6
Foundation), and Molt3 (ATCC) were maintained in RPMI-1640
medium containing 10% FBS and 50 μg/ml gentamycin. Human
embryonic kidney-293 cells (HEK-293) and HHV-6A in vitro inte-
grated cells previously established in our lab (Arbuckle et al., 2010)
were maintained in DMEM supplemented with 10% FBS. HHV-6A
(U1102 strain) and HHV-6B (Z29 strain) viruses were obtained from
Dr. Philip Pellett (Wayne State University).Infection of cell lines with HHV-6 in vitro to study integration
After removal of dead cells using Lymphoprep™ isotonic
density gradient, 107 T-cells were infected with HHV-6A (U1102)
and HHV-6B (Z29) at 1.0 MOI in 1 ml of RPMI-1640 complete for
2 h at 371C. Speciﬁcally, the T-cell lines Jjhan and Molt3, were
infected with HHV-6A and HHV-6B, respectively. Unabsorbed
virus was removed by centrifugation for 5 min at 470 g, 251C(Fisher accuSpin 1R). Cell pellet was resuspended to 106 cells/ml
and incubated at 371C, 5% CO2.
Reactivation of chromosome integrated HHV-6
PBMCs were cultured in RPMI-1640 medium containing 10%
FBS and various concentrations of Trichostatin (TSA), or alterna-
tively, 12-O-Tetradecanoyl-13 acetate (TPA) ﬁnal concentration of
10 ng/ml and 10 μM hydrocortisone as previously described by
Arbuckle et al. (2010). DNA was prepared from cells following the
time of peak cytopathic effect (5–14 days).
Chromosome-speciﬁc PCR for HHV-6B integration
The PCR ampliﬁcation of HHV-6B integration sites included:
400 ng genomic DNA, 50 mM HHV-6 DRR chromosome speciﬁc
primers, 500 mM dNTPs, Expand 20 kbPLUS PCR system (Roche
Diagnostics, Indianapolis, IN), 10 X Taq buffer, and ﬁnal volume was
increased to 25 ml with H2O. Samples were ampliﬁed with the Peltier
Thermal Cycler PCR (PTC-220, MJ Research Inc, Waltham, Ma) and
subjected to the following PCR conditions: 941C for 2 min, which is
then followed by 35 cycles of 941C for 10 s, 641C for 30 s, and 681C for
10 min, and completed with a ﬁnal extension of 681C for 7 min.
Agarose gel electrophoresis and Southern blot hybridization with
telomere, HHV-6, and chromosome speciﬁc [γ32P]-ATP-radiolabeled
oligonucleotide probes were utilized for identifying DNA bands
representing the putative viral-chromosomal DNA junction. Bands
were gel extracted with Perfectpreps Gel Cleanup Kit (Eppendorf,
Westbury, NY) and cloned with pCRs4-TOPOs (TOPO TA Clonings
Kit for Sequencing, Invitrogen, Carlsbad, CA). A minimum of three
clones from each sample was sequenced.
Single telomere length analysis (STELA)
Genomic DNA was isolated from PBMCs of patients with
inherited HHV-6A and HHV-6B and from HEK-293 cells carrying
J.H. Arbuckle et al. / Virology 442 (2013) 3–1110integrated HHV-6A (Arbuckle et al., 2010). Oligonucleotide linker
(Tellorette-2) containing a single TTAGGG repeat was ligated to the
end of the telomere by incubating 60–150 ng of genomic DNA, 60–
100 mM of oligonucleotide Telorette-2, and 4.5 U of T4 DNA ligase
for 13 h at 351C. The ligation reaction was then puriﬁed through
phenol chloroform extraction, ethanol precipitation, and resus-
pended in 15 ml TE. Serial dilution of Telorette-2-ligated-DNA was
ampliﬁed with a high ﬁdelity taq polymerase (Expand 20 kbPLUS
PCR System, Roche), 25 mM linker annealing primer (Teltail-P1),
25 mM HHV-6 STELA-P2. Cycling conditions were 921C for 2 min,
27 cycles of 921C for 15 s, 591C for 30 s, 681C 13.5 min or 18 min,
and a ﬁnal extension of 681C for 7 min. Ampliﬁcation products
were separated through electrophoresis on a 0.8% agarose gel and
Southern hybridized with [γ32P]-ATP-radiolabeled telomere oligo-
nucleotide probe and PCR ampliﬁed (primers P3+P4) HHV-6 DRL
random primer [α32P]-dATP-radiolabeled probe. Telomere length
linked to integrated HHV-6 was then calculated based upon the
mean molecular weight of bands co-hybridizing with telomere
and HHV-6 DRL probes.
Reactivation of integrated HHV-6
PBMCs were cultured in RPMI-1640 medium containing 10% FBS
and various concentrations of Trichostatin (TSA), or alternatively,
12-O-Tetradecanoyl-13 acetate (TPA) ﬁnal concentration of 10 ng/ml
and 10 μM hydrocortisone as described by Arbuckle et al. (2010).
Primer sequences
Oligonucleotides for chromosome-speciﬁc PCR and probe:
HHV-6 DRR: 5′-CATAGATCGGGACTGCTTGAAAGCGC-3′ (Arbuckle
et al., 2010)
HHV-6 DRR-probe: 5′-GCGGAGACACATAGCCTTGGCGGGAAGAC-3′
Chromosome 2p: 5′-GAGCTGCGTTTTGCTGAGCAC (Baird et al.,
2003)
Chromosome 11q: 5′-CAGACCTTGGAGGCACGGCCTTCG-3′ (Baird
et al., 2003)
Chromosome 17p: 5′-AACATCGAATCCACGGATTGCTTTGTGTAC-3′
(Baird et al., 2003)
Chromosome 18q: 5′-CTCATGTCCTCGGTCTCTTGCCTC-3′ (Arbuckle
et al., 2010)
Telomere Probe: 5′-TTAGGGTTAGGGTTAGGGTTAGGG-3′ (Arbuckle
et al., 2010)
DRL PCR:P1: 5′-ATGTGGCGATCATCCAATCAACGG-3′
P2: 5′-AAATGTCTGCGGAAAGGTCAACCG-3′
P3: 5′-CATAGATCGGGACTGCTTGAAAGCGG-3′
P4: 5′- AAATGTCTGCGGAAAGGTCAACCG-3′
HHV-6 DRL Probe: 5′-CCCCAACGCGCGCGCGCACGC-3′Oligonucleotides for STELA PCR and probe:
Tellorette-2 (Linker): 5′-TGCTCCGTGCATCTGGCATCTAACCCT-3′
(Baird et al., 2003)
P1-Teltail: 5′-TGCTCCGTGCATCTGGCATC-3′ (Baird et al., 2003)
P2-HHV6 STELA: 5′-AAGGATGGTAGGGTTTAGGGTCGAACC-3′
P3-HHV6 STELA: 5′-CCCTAACACTAATCCTCGCATCCGC-3′
XpYpE2: 5′-TTGTCTCAGGGTCCTAGTG-3′ (Baird et al., 2003)
XpYpB2: 5′-TCTGAAAGTGGACCTATCAG-3′ (Baird et al., 2003)Acknowledgments We thank Dr. Philip Pellett providing HHV-
6A and 6B stocks. This work was supported by a grant from theHHV-6 Foundation and the National Institute of Health
5R01CA111196 for PGM.
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